3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
4
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Neurocognitive Disorders
1
Meningioma
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin G4-Related Disease
1
Carcinoma, Renal Cell
1
Carcinoma, Adenoid Cystic
1
Carcinoma
1
Breast Carcinoma In Situ
1
Autoimmune Pancreatitis
1
Anus Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Cisplatin
6
Paclitaxel
4
pembrolizumab
3
Fluorouracil
3
Carboplatin
3
tislelizumab
2
Taxes
2
Radiotherapy
2
Oxaliplatin
2
Leucovorin
2
Irinotecan
2
Injections
2
Capecitabine
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
lenvatinib
1
durvalumab
1
cixutumumab
1
apatinib
1
Tegafur
1
Surgical Procedures, Operative
1
Saline Solution
1
Radiation
1
Levoleucovorin
1
Laparoscopy
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Fulvestrant
1
Docetaxel
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Observation
×
30 days
×
Clear all
No trials found.